4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-004154
Options or other derivatives
- Chief Financial Officer acquired 1,721,328 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Wood Gavin Chief Financial Officer | 2022-01-12 | Grant or award · Option to purchase Ordinary Shares | +1,407,072 | 1,407,072 | D | ||
| Wood Gavin Chief Financial Officer | 2022-01-12 | Grant or award · Option to purchase Ordinary Shares | +314,256 | 314,256 | D | ||
Loading xslF345X03/tm221700-7_4seq1.xml…